Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma

被引:4
作者
Wei, Zongjie [1 ]
Zhang, Fan [2 ]
Ma, Xin [2 ]
He, Weiyang [1 ]
Gou, Xin [1 ]
Zhang, Xu [2 ]
Xie, Yongpeng [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, 1 Youyi Rd,Yuzhong Dist, Chongqing 400016, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 3, Dept Urol, Beijing, Peoples R China
关键词
Renal cell carcinoma; Red blood cell distribution width; Biomarker; Prognosis; EXTERNAL VALIDATION; TARGETED THERAPY; CANCER; 1ST-LINE; MODELS; TOOL;
D O I
10.1016/j.tranon.2022.101486
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study aimed to explore the prognostic value of preoperative red blood cell distribution width (RDW) in patients with metastatic renal cell carcinoma (mRCC). Methods: Clinicopathological data of 230 patients with mRCC treated at the First Affiliated Hospital of Chongqing Medical University and the Chinese PLA General Hospital from January 2008 to December 2018 were retrospectively analyzed. Patients were stratified according to the optimal cut-off value of RDW calculated using X-tile software. The prognostic value of RDW was analyzed using the Kaplan-Meier curve with log-rank test and univariate and multivariate Cox proportional hazards models. Results: A total of 230 patients were included. The optimal cut-off value of RDW obtained using X-tile software was 13.1%. The median Progression-free survival (PFS) and Overall survival (OS) of all populations were 12.06 months (IQR: 4.73-36.9) and 32.20 months (IQR: 13.73-69.46), respectively. Kaplan-Meier curves showed that patients with high RDW had worse PFS and OS than those with low RDW (median PFS of 9.7 months vs. 17.9 months, P = 0.002, and median OS of 27.8 months vs. 45.1 months, P = 0.012, respectively). Multivariate analysis showed that RDW was an independent risk factor for PFS (HR: 1.505; 95% CI: 1.111-2.037; P = 0.008) and OS (HR: 1.626; 95% CI: 1.164-2.272; P = 0.004) in mRCC after cytoreductive nephrectomy. Conclusion: Preoperative RDW was independently associated with PFS and OS in patients with mRCC and may be a potential predictor of survival outcomes in mRCC.
引用
收藏
页数:6
相关论文
共 24 条
[1]   The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy [J].
Aktepe, Oktay Halit ;
Guven, Deniz Can ;
Sahin, Taha Koray ;
Yildirim, Hasan Cagri ;
Celikten, Burcu ;
Yeter, Haci Hasan ;
Yuce, Deniz ;
Dizdar, Omer ;
Erman, Mustafa .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (10) :1957-1963
[2]  
[Anonymous], 2020, CA-CANCER J CLIN, V70, P7
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[4]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[5]   Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical Templates [J].
Crispen, Paul L. ;
Breau, Rodney H. ;
Allmer, Cristine ;
Lohse, Christine M. ;
Cheville, John C. ;
Leibovich, Bradley C. ;
Blute, Michael L. .
EUROPEAN UROLOGY, 2011, 59 (01) :18-23
[6]   Cancer-related inflammation and treatment effectiveness [J].
Diakos, Connie I. ;
Charles, Kellie A. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
LANCET ONCOLOGY, 2014, 15 (11) :E493-E503
[7]   Prognostic value of red blood cell distribution width in hepatocellular carcinoma [J].
Goyal, Hemant ;
Hu, Zhi-De .
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (13)
[8]   External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study [J].
Heng, Daniel Y. C. ;
Xie, Wanling ;
Regan, Meredith M. ;
Harshman, Lauren C. ;
Bjarnason, Georg A. ;
Vaishampayan, Ulka N. ;
Mackenzie, Mary ;
Wood, Lori ;
Donskov, Frede ;
Tan, Min-Han ;
Rha, Sun-Young ;
Agarwal, Neeraj ;
Kollmannsberger, Christian ;
Rini, Brian I. ;
Choueiri, Toni K. .
LANCET ONCOLOGY, 2013, 14 (02) :141-148
[9]   The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma [J].
Huszno, Joanna ;
Kolosza, Zofia ;
Mrochem-Kwarciak, Jolanta ;
Rutkowski, Tomasz ;
Skladowski, Krzysztof .
ONCOLOGY, 2019, 97 (01) :7-17
[10]   International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study [J].
Ko, Jenny J. ;
Xie, Wanling ;
Kroeger, Nils ;
Lee, Jae-Lyun ;
Rini, Brian I. ;
Knox, Jennifer J. ;
Bjarnason, Georg A. ;
Srinivas, Sandy ;
Pal, Sumanta K. ;
Yuasa, Takeshi ;
Smoragiewicz, Martin ;
Donskov, Frede ;
Kanesvaran, Ravindran ;
Wood, Lori ;
Ernst, D. Scott ;
Agarwal, Neeraj ;
Vaishampayan, Ulka N. ;
Rha, Sun-young ;
Choueiri, Toni K. ;
Heng, Daniel Y. C. .
LANCET ONCOLOGY, 2015, 16 (03) :293-300